Kennythematics
voted
Spoiler:
At the end of this post, there is a chance for you to win points!
Happy Monday, mooers! Welcome back to Weekly Buzz, where we review the news, performance, and community sentiment of the selected buzzing stocks on moomoo platform based on search and message volumes of last week! (Nano caps are excluded.)
Part Ⅰ: Make Your Choices
Part Ⅱ: Buzzing Stocks List & Mooers Comments
Three major indices moved upward, Russell 2000 Index increa...
At the end of this post, there is a chance for you to win points!
Happy Monday, mooers! Welcome back to Weekly Buzz, where we review the news, performance, and community sentiment of the selected buzzing stocks on moomoo platform based on search and message volumes of last week! (Nano caps are excluded.)
Part Ⅰ: Make Your Choices
Part Ⅱ: Buzzing Stocks List & Mooers Comments
Three major indices moved upward, Russell 2000 Index increa...
![Weekly Buzz: How does Fed trapering affect markets?](https://ussnsimg.moomoo.com/1654496332660-random4798-77777000-android-org.gif/thumb)
![Weekly Buzz: How does Fed trapering affect markets?](https://ussnsimg.moomoo.com/1654498833317-random7433-77777000-android-org.png/thumb)
![Weekly Buzz: How does Fed trapering affect markets?](https://ussnsimg.moomoo.com/1654498833344-random1474-77777000-android-org.png/thumb)
39
63
Kennythematics
liked
- US buybacks hit record levels
US companies announced more than $300 billion in new buybacks in the first quarter, with March seeing a robust year-over-year increase, suggesting buyback activities have sustained resilience in recent weeks, according to financial data firms EPFR and Informa Financial Intelligence.
New buybacks announced in March reached about $74 billion, up from $54 billion in March 2021, Informa Financial Intelli...
US companies announced more than $300 billion in new buybacks in the first quarter, with March seeing a robust year-over-year increase, suggesting buyback activities have sustained resilience in recent weeks, according to financial data firms EPFR and Informa Financial Intelligence.
New buybacks announced in March reached about $74 billion, up from $54 billion in March 2021, Informa Financial Intelli...
![US buybacks hit a record in Q1. Could they continue through 2022?](https://ussnsimg.moomoo.com/847341665241930519.png/thumb)
![US buybacks hit a record in Q1. Could they continue through 2022?](https://ussnsimg.moomoo.com/4684353237512961860.png/thumb)
![US buybacks hit a record in Q1. Could they continue through 2022?](https://ussnsimg.moomoo.com/8937921459359312782.jpg/thumb)
48
6
Kennythematics
liked and voted
On Saturday, Warren Buffett, arguably the world's most closely watched investor, released his highly anticipated annual letter to shareholders.
His hedge fund, $Berkshire Hathaway-A(BRK.A.US$ , had one of the best performers in 2021. YoY growth 29.6% outperformed $S&P 500 Index(.SPX.US$ 's 28.7%. And it looked to have an even better 2022 as the Federal Reserve prepares to raise interest rates.
However, over the last decade, Buff...
His hedge fund, $Berkshire Hathaway-A(BRK.A.US$ , had one of the best performers in 2021. YoY growth 29.6% outperformed $S&P 500 Index(.SPX.US$ 's 28.7%. And it looked to have an even better 2022 as the Federal Reserve prepares to raise interest rates.
However, over the last decade, Buff...
![Daily Poll: Should value investors still follow Warren Buffett?](https://ussnsimg.moomoo.com/1646029186117-77777000-android-org.gif/thumb)
33
5
up back to all time high !
3
Kennythematics
liked and voted
U.S. stock indexes closed higher in the holiday-shortened trading week, with the $S&P 500 Index(.SPX.US$ notching a new high.
The S&P 500 was up 0.6%, or 29.23 points, to 4725.79, its 68th
record close in 2021. Thursday's rise, its third consecutive dailyincrease, followed a Wednesday session during which strong
economic data helped ease investors' concerns about the risks posed by Covid-19 and inflation.
The tech-focused $Nasdaq Composite Index(.IXIC.US$ rose 0.85%, or 131.48 points, to 15653.37. The $Dow Jones Industrial Average(.DJI.US$ added 0.55%, or 196.67 points, to 35950.56.
The S&P 500 was up 0.6%, or 29.23 points, to 4725.79, its 68th
record close in 2021. Thursday's rise, its third consecutive dailyincrease, followed a Wednesday session during which strong
economic data helped ease investors' concerns about the risks posed by Covid-19 and inflation.
The tech-focused $Nasdaq Composite Index(.IXIC.US$ rose 0.85%, or 131.48 points, to 15653.37. The $Dow Jones Industrial Average(.DJI.US$ added 0.55%, or 196.67 points, to 35950.56.
![Daily Poll: S&P 500 marking a record-high close!](https://ussnsimg.moomoo.com/1640319801340-77777000-android-org.gif/thumb)
39
Kennythematics
liked
Let's see the biggest movers for this week.![]()
![]()
Top 10 movers for large-cap value stocks![]()
![]()
Large-Cap Value Stocks: Stocks of large-cap companies that are less expensive or growing more slowly than other large-cap stocks. Value is defined based on low valuations (low price ratios and high dividend yields) and slow growth (low growth rates for earnings, sales, book value, and cash flow).
Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.
Top 10 movers for large-cap growth stocks![]()
![]()
Stocks of large-cap companies that are projected to grow faster than other large-cap stocks. Growth is defined based on fast growth (high growth rates for earnings, sales, book value, and cash flow) and high valuations (high price ratios and low dividend yields).
Top 10 movers for large-cap core stocks![]()
![]()
Large-Cap Core Stocks: Stocks of large-cap companies where neither growth nor value characteristics predominate.
Source: Moomoo, morningstar
Top 10 movers for large-cap value stocks
Large-Cap Value Stocks: Stocks of large-cap companies that are less expensive or growing more slowly than other large-cap stocks. Value is defined based on low valuations (low price ratios and high dividend yields) and slow growth (low growth rates for earnings, sales, book value, and cash flow).
Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.
Top 10 movers for large-cap growth stocks
Stocks of large-cap companies that are projected to grow faster than other large-cap stocks. Growth is defined based on fast growth (high growth rates for earnings, sales, book value, and cash flow) and high valuations (high price ratios and low dividend yields).
Top 10 movers for large-cap core stocks
Large-Cap Core Stocks: Stocks of large-cap companies where neither growth nor value characteristics predominate.
Source: Moomoo, morningstar
![Weekly Recap | Movers for large-cap stocks](https://ussnsimg.moomoo.com/7550933656361000811.png/thumb)
![Weekly Recap | Movers for large-cap stocks](https://ussnsimg.moomoo.com/3722631427729881218.png/thumb)
![Weekly Recap | Movers for large-cap stocks](https://ussnsimg.moomoo.com/5255148911074020622.png/thumb)
75
3
Kennythematics
liked
By Julianna
Investors appear to be losing patience with Ark Investment Management's genomics fund.![]()
![]()
$ARK Genomic Revolution ETF(ARKG.US$ is an actively managed ETF that focus on health care, information technology, materials, energy, and consumer discretionary.
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
- according to ARKG fund description.
However, ARKG is down 30% this year as investors shun health-care stocks in favor for more cyclical names that perform well during an economic recovery. Even so, this ETF is faring far worse than the broader biotech sector, with the $Dow Jones U.S. Biotechnology Index(.DJUSBT.US$up 11.35% this year.![]()
![]()
ARKG is currently trading at $65.16 a share, 43% lower from its peak in this February. The genomics fund has also seen the largest outflows among Ark's ETFs this year.![]()
![]()
It's interesting that typically loyal Ark investors have been bailing on the ETF.
The fund's assets have been chopped in half since February. While I don't believe the ETF is experiencing some of sort of 'doom loop,' clearly the outflows are putting downward price pressure on the underlying holdings and testing the will of remaining fund owners.
- said Nate Geraci, president of The ETF Store, an advisory firm.
![]()
FOLLOW ME to know more about ETFs
PLZ leave your comments and likes below![]()
ARKG's top two holdings, $Teladoc Health(TDOC.US$and $Exact Sciences(EXAS.US$, heavily impact its performance, with drops of 47% and 33.5% this year, respectively.![]()
![]()
![]()
The recent outflows may be due to investors looking for shorter-term opportunities into the year-end and freeing up cash.
- said Sylvia Jablonski, chief investment officer at Defiance ETFs.
Ark Chief Executive Officer Cathie Wood is well-known for prioritizing longer term investments over short-term gains.![]()
![]()
This is a 5-10 year hold. AI in health care is going to change the way that we can predict, treat and manage the most difficult diseases like cancer, and the Ark fund gives investors access to the companies who are on the cutting edge of that research.
- Jablonski added.
Have you ever invested in the Biotechnology sector? Do you agree with Jablonski's opinion?![]()
![]()
Source: Bloomberg
Investors appear to be losing patience with Ark Investment Management's genomics fund.
$ARK Genomic Revolution ETF(ARKG.US$ is an actively managed ETF that focus on health care, information technology, materials, energy, and consumer discretionary.
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
- according to ARKG fund description.
However, ARKG is down 30% this year as investors shun health-care stocks in favor for more cyclical names that perform well during an economic recovery. Even so, this ETF is faring far worse than the broader biotech sector, with the $Dow Jones U.S. Biotechnology Index(.DJUSBT.US$up 11.35% this year.
ARKG is currently trading at $65.16 a share, 43% lower from its peak in this February. The genomics fund has also seen the largest outflows among Ark's ETFs this year.
It's interesting that typically loyal Ark investors have been bailing on the ETF.
The fund's assets have been chopped in half since February. While I don't believe the ETF is experiencing some of sort of 'doom loop,' clearly the outflows are putting downward price pressure on the underlying holdings and testing the will of remaining fund owners.
- said Nate Geraci, president of The ETF Store, an advisory firm.
PLZ leave your comments and likes below
ARKG's top two holdings, $Teladoc Health(TDOC.US$and $Exact Sciences(EXAS.US$, heavily impact its performance, with drops of 47% and 33.5% this year, respectively.
The recent outflows may be due to investors looking for shorter-term opportunities into the year-end and freeing up cash.
- said Sylvia Jablonski, chief investment officer at Defiance ETFs.
Ark Chief Executive Officer Cathie Wood is well-known for prioritizing longer term investments over short-term gains.
This is a 5-10 year hold. AI in health care is going to change the way that we can predict, treat and manage the most difficult diseases like cancer, and the Ark fund gives investors access to the companies who are on the cutting edge of that research.
- Jablonski added.
Have you ever invested in the Biotechnology sector? Do you agree with Jablonski's opinion?
Source: Bloomberg
![Cathie Wood's ARKG is down 30%, and investors are pulling money out of it](https://ussnsimg.moomoo.com/2438077168151774024.png/thumb)
![Cathie Wood's ARKG is down 30%, and investors are pulling money out of it](https://ussnsimg.moomoo.com/7817133869407687573.png/thumb)
![Cathie Wood's ARKG is down 30%, and investors are pulling money out of it](https://ussnsimg.moomoo.com/6450570388144939558.png/thumb)
+1
128
25
Kennythematics
liked
Kennythematics
liked
The result of a $Twitter (Delisted)(TWTR.US$ poll by $Tesla(TSLA.US$ CEO Elon Musk is final, and a majority of his followers say he should sell 10% of his company stock.
On Saturday, Musk tweeted a poll asking his followers to vote on his decision, saying the survey was in response to concerns about unrealized gains being a way for wealthy people to avoid paying taxes.
The final result of the 3,519,252 votes was that 57.9% supported the sale, while 42.1% were opposed. Musk tweeted on Sunday that he acknowledged the results.
On Saturday, Musk tweeted a poll asking his followers to vote on his decision, saying the survey was in response to concerns about unrealized gains being a way for wealthy people to avoid paying taxes.
The final result of the 3,519,252 votes was that 57.9% supported the sale, while 42.1% were opposed. Musk tweeted on Sunday that he acknowledged the results.
![Elon Musk Twitter Followers Vote For The Tesla CEO To Sell 10% Of His Company Holdings](https://ussnsimg.moomoo.com/1636338850496-70042948-android-org.png/thumb)
4
1